Abstract
Synthetic biology has not yet raised substantial public debate in Austria. Against this background a series of citizen panels (CPs) with members of the Austrian public were conducted in November and December 2012. The CPs should offer citizens from a variety of backgrounds the possibility to discuss synthetic biology and give recommendations on its governance. The project was guided by the following questions: How do members of the Austrian public perceive synthetic biology? Which associations do they make and which frames emerge within their discussions? How do they discuss risks and opportunities of synthetic biology, and how are perceived challenges dealt with? Which issues are seen as relevant for synthetic biology governance? All discussions within the CPs were audio recorded, transcribed, and analyzed using structured content analysis and interpretive frame analysis. The results show that beyond openly stated opinions, hopes, and concerns about issues known from scientific debates—such as long-term impacts, distributional justice, safety and security of synthetic biology—a number of latent attitudes towards synthetic biology and its governance emerged. These included an attitude of making sense of synthetic biology by drawing parallels to familiar research fields, most notably genetic engineering, and elements of distrust in science and governance authorities, resignation, or self-activation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Female participant in CP 1, adults aged 50+, Vienna.
Citizen panels were conducted in German and transcripts quoted in this chapter have been translated to English by the author.
- 2.
The anti-GMO movement in Europe at the end of the 1990s was triggered by two events: (1) the import of GM crops—not labeled as such—from the U.S. to Europe, (2) the outbreak of the BSE scandal. Within this context, Austria was one of the first countries where anti-GMO movements emerged (Seifert 2002, 2003).
- 3.
www.syntheticbiology.org. Accessed 25 Mar 2015.
- 4.
The CPs were conducted in the framework of work provided to the Austrian Research Promotion Agency (FFG). The citizen panel study was coordinated and supervised by Herbert Gottweis.
- 5.
Also the design of CPs is characterized heterogeneously in the scientific literature, which is due to the association of the term with completely different engagement mechanisms (Rowe and Frewer 2005). Accordingly, designs of CPs range from discussions within small groups of participants assumed to represent a specific community (Abelson et al. 2006; Guston 1999; Sheedy et al. 2008), to projects involving several hundred participants constituting a statistically representative sample and having more the form of surveys (Abelson et al. 2003; Nanz et al. 2010). Meetings are in some cases organized as singular events and in others as a sequence of meetings over a longer time period, with a selected standing group of participants.
- 6.
In this connection it is important to know about two events that are considered particularly significant for Austria’s political culture and popular understanding of protest and democracy. First, during the 1970s a protest movement formed against the activation of the nuclear power plant “Zwentendorf”—ever since, Austria has been nuclear-free in electricity production. Second, in the mid-1980s a protest movement and mass-occupation of the wetland “Hainburger Au” hindered the construction of a hydroelectric power plant in the nature reserve. As a consequence of protester’s demonstrations, the natural ecosystem of the “Hainburger Au” has been left untouched until today and Austria’s national energy policy deeply influenced by the event (Seifert 2002).
- 7.
Participant recruitment was carried out by Ursula Gottweis, Walburg Steurer, and Viktoria Veith.
- 8.
The CPs were organized and conducted by Ursula Gottweis and Walburg Steurer.
- 9.
Regarding the composition of the thematic units and selection of example cases the topic guide was inspired by those used in the UK “Synthetic Biology Dialogue” by BBSRC and EPSRC (2010) and in the public dialogue organized by the Royal Academy of Engineering (2009). Furthermore, case selection was inspired by a focus group study conducted by a group of researchers from the Chair of Ethics at the Friedrich-Alexander University Erlangen-Nuremberg, which is yet to be published.
- 10.
Male participant in CP 8, adults aged 50+, Innsbruck.
- 11.
Conversation between two male participants in CP 6, adults aged 18–49, Innsbruck.
- 12.
Male participant in CP 1, adults aged 50+, Vienna.
- 13.
These terms are known in German under the buzzwords “Analog-Käse” and “Mogel-Schinken”, which had been at the centre of heated public debates throughout the previous five years (Die Welt 2009).
- 14.
Male participant in CP 2, adults aged 18–49, Vienna.
- 15.
Male participant in CP 6, adults aged 18–49, Innsbruck.
- 16.
Male participant in CP 7, adults aged 50+, Innsbruck.
- 17.
Contergan was the trade name of a drug containing thalidomide, which was freely available in pharmacies in Western Germany from 1957 to 1961. It was, amongst others, used against morning sickness in pregnant women, and caused severe damage to children, most notably with regard to limb development.
- 18.
Female participant in CP 5, adults aged 18–49, Innsbruck.
- 19.
Male participant in CP 1, adults aged 50+, Vienna.
- 20.
Male participant in CP 1, adults aged 50+, Vienna.
- 21.
Conversation between two male participants in CP 8, adults aged 50+, Innsbruck.
- 22.
Female participant in CP 5, adults aged 18–49, Innsbruck.
- 23.
Male participant in CP 8, adults aged 50+, Innsbruck.
- 24.
Conversation between two male (P1, P2), and two female (P3, P6) participants in CP 5, adults aged 18–49, Innsbruck.
- 25.
Female participant in CP 4, adults aged 18–49, Vienna.
- 26.
Conversation between a female (P1) and a male (P11) participant in CP 8, adults aged 50+, Innsbruck.
- 27.
Female participant in CP 3, adults aged 50+, Vienna.
- 28.
Conversation between a female (P5) and three male (P2, P6, P9) participants in CP 8, adults aged 50+, Innsbruck.
- 29.
Conversation between two male participants in CP 7, adults aged 50+, Innsbruck.
- 30.
Male participant in CP 6, adults aged 18–49, Innsbruck.
- 31.
Male participant in CP1, adults aged 50+, Vienna.
- 32.
Male participant in CP 3, adults aged 50+, Vienna.
- 33.
Female participant in CP 1, adults aged 50+, Vienna.
- 34.
Conversation between a female (P1) and a male (P2) participant in CP 6, adults aged 18–49, Innsbruck.
- 35.
Conversation between a female (P2) and two male (P1, P4) participants in CP 7, adults aged 50+, Innsbruck.
- 36.
Conversation between a male (P1) and two female (P3, P6) participants in CP 5, adults aged 18–49, Innsbruck.
- 37.
Male participant in CP 5, adults aged 18–49, Innsbruck.
- 38.
Male participant in CP 8, adults aged 50+, Innsbruck.
- 39.
Conversation between two male participants in CP8, adults aged 50+, Innsbruck.
- 40.
Female participant in CP 2, adults aged 18–49, Vienna.
- 41.
Female participant in CP 4, adults aged 18–49, Vienna.
- 42.
Female participant in CP 4, adults aged 18–49, Vienna.
- 43.
Female participant in CP 1, adults aged 50+, Vienna.
References
Abelson J, Eyles J, McLeod CB, Collins P, McMullan C, Forest P-G (2003) Does deliberation make a difference? Results from a citizens panel study of health goals priority setting. Health Policy 66(1):95–106
Abelson J, Gauvin F-P, MacKinnon MP, Watling J (2006) Primer on public involvement. Document prepared for the Health Council of Canada
Andrianantoandro E, Basu S, Karig DK, Weiss R (2006) Synthetic biology: new engineering rules for an emerging discipline. Mol Syst Biol 2(2006):0028
Ball P (2004) Synthetic biology: starting from scratch. Nature 431(7009):624–626
Ball P (2010) Making life: a comment on ‘Playing god in Frankenstein’s footsteps: synthetic biology and the meaning of life’ by Henk van den Belt (2009). Nanoethics 4(2):129–132. doi:10.1007/s11569-010-0091-x
Barbour R (2008) Doing focus groups. Sage, London
Barbour R (2014) Introducing qualitative research: a students guide, 2nd edn. Sage, London
BBSRC, EPSRC (2010) Synthetic biology dialogue. http://www.bbsrc.ac.uk/web/FILES/Reviews/1006-synthetic-biology-dialogue.pdf. Accessed 17 June 2015
Benner SA, Sismour AM (2005) Synthetic biology. Nat Rev Genet 6(7):533–543
Bloor M, Frankland J, Thomas M, Robson K (2001) Focus groups in social research. Sage, London
Bogner A (2012) The paradox of participation experiments. Sci Technol Hum Values 37(5):506–527. doi:10.1177/0162243911430398
Brown MB (2006) Survey article: citizen panels and the concept of representation. J Polit Philos 14(2):203–225
Calvert J, Martin P (2009) The role of social scientists in synthetic biology. EMBO Rep 10(3):201–204
Collins J (2012) Synthetic biology: bits and pieces come to life. Nature 483(7387):S8–S10
Crosby N, Kelly JM, Schaefer P (1986) Citizens panels: a new approach to citizen participation. Pub Adm Rev 46(2):170–178. doi:10.2307/976169
Cserer A, Seiringer A (2009) Pictures of synthetic biology: a reflective discussion of the representation of synthetic biology (SB) in the German-language media and by SB experts. Syst Synth Biol 3(1–4):27–35
Dabrock P (2009) Playing God? Synthetic biology as a theological and ethical challenge. Syst Synth Biol 3(1–4):47–54. doi:10.1007/s11693-009-9028-5
De Lorenzo V, Danchin A (2008) Synthetic biology: discovering new worlds and new words. EMBO Rep 9(9):822–827
De Vriend H (2006) Constructing life. Early social reflections on the emerging field of synthetic biology. Working document 97, The Hague
Delgado A, Lein Kjølberg K, Wickson F (2011) Public engagement coming of age: from theory to practice in STS encounters with nanotechnology. Pub Underst Sci 20(6):826–845. doi:10.1177/0963662510363054
Deplazes A, Huppenbauer M (2009) Synthetic organisms and living machines: positioning the products of synthetic biology at the borderline between living and non-living matter. Syst Synth Biol 3(1):55–63
Die Welt (2009) Nach Analog-Käse nun der Mogel-Schinken. http://www.welt.de/wissenschaft/article4049225/Nach-Analog-Kaese-nun-der-Mogel-Schinken.html. Accessed 25 Mar 2015
Dragojlovic N, Einsiedel E (2012) Playing God or just unnatural? Religious beliefs and approval of synthetic biology. Pub Underst Sci doi:10.1177/0963662512445011
Endy D (2005) Foundations for engineering biology. Nature 438(7067):449–453
Engelhard M (2010) Biosicherheit in der Synthetischen Biologie. Die Unterschiede zur Gentechnik erfordern neue Sicherheitsstandards. Die Politische Meinung 493:17–22
Engelhard M (2011) Die Synthetische Biologie geht weit über die klassische Gentechnik hinaus. In: Dabrock P, Bölker M, Braun M, Ried J (eds) Was ist Leben – im Zeitalter seiner technischen Machbarkeit? Beiträge zur Ethik der Synthetischen Biologie. Karl Alber, Freiburg, pp 43–60
ETC Group (2007) Extreme genetic engineering: an introduction to synthetic biology. http://www.etcgroup.org/sites/www.etcgroup.org/files/publication/602/01/synbioreportweb.pdf. Accessed 21 Aug 2013
European Group on Ethics (2009) Opinion no. 25—ethics of synthetic biology
Fiorino DJ (1990) Citizen participation and environmental risk: a survey of institutional mechanisms. Sci Technol Hum Values 15(2):226–243. doi:10.2307/689860
Fischer F (2003) Reframing public policy: discursive politics and deliberative practices. Oxford University Press, Oxford
Friends of the Earth, International Center for Technology Assessment, ETC Group (2012) The principles for the oversight of synthetic biology. http://www.etcgroup.org/sites/www.etcgroup.org/files/The-Principles-for-the-Oversight-of-Synthetic-Biology-FINAL.pdf. Accessed 3 Aug 2015
Friese S (2012) Qualitative data analysis with ATLAS.ti. Sage Publications, London
Gaskell G, Stares S, Allansdottir A, Allum N, Castro P, Esmer Y et al (2010) Europeans and biotechnology in 2010. Winds of change? Eurobarometer
Georgianna DR, Mayfield SP (2012) Exploiting diversity and synthetic biology for the production of algal biofuels. Nature 488(7411):329–335
Gilbert LI, Gill SS (eds) (2010) Insect control: biological and synthetic agents. Elsevier, London
Gimpel JA, Specht EA, Georgianna DR, Mayfield SP (2013) Advances in microalgae engineering and synthetic biology applications for biofuel production. Current Opin Chem Biol 17(3):489–495. doi:10.1016/j.cbpa.2013.03.038
Graur D (2007) Public control could be a nightmare for researchers. Nature 450(7173):1156
Gschmeidler B, Seiringer A (2012) “Knight in shining armour” or “Frankenstein’s creation”? The coverage of synthetic biology in German-language media. Pub Underst Sci 21(2):163–173. doi:10.1177/0963662511403876
Guston DH (1999) Evaluating the first U.S. consensus conference: the impact of the citizens’ panel on telecommunications and the future of democracy. Sci Technol Hum Values 24(4):451–482. doi:10.1177/016224399902400402
Hart Research Associates (2008) Awareness of and attitudes toward nanotechnology and synthetic biology: a report of findings. http://www.nanotechproject.org/process/assets/files/7040/final-synbioreport.pdf. Accessed 3 Aug 2015
Hart Research Associates (2009) Nanotechnology, synthetic biology, and public opinion. http://www.wilsoncenter.org/sites/default/files/nano_synbio.pdf. Accessed 17 June 2015
Hart Research Associates (2010) Awareness and impressions of synthetic biology: a report of findings. http://www.synbioproject.org/library/publications/archive/6456. Accessed 16 Sept 2013
Hart Research Associates (2013) Awareness and impressions of synthetic biology: a report of findings. http://www.wilsoncenter.org/sites/default/files/synbiosurvey2013_0.pdf. Accessed 3 Aug 2015
Hommel M (2008) The future of artemisinins: natural, synthetic or recombinant? J Biol 7(10):38
Irwin A, Jensen TE, Jones KE (2013) The good, the bad and the perfect: criticizing engagement practice. Soc Stud Sci 43(1):118–135. doi:10.1177/0306312712462461
Jin L, Walker AS, Fu G, Harvey-Samuel T, Dafa’alla T, Miles A, Marubbi T, Granville D, Humphrey-Jones N, O’Connell S, Morrison NI, Alphey L (2013) Engineered female-specific lethality for control of pest lepidoptera. ACS Synth Biol 2:160–166
Kahan DM, Braman D, Mandel GN (2009) Risk and Culture: Is Synthetic Biology Different? Harvard law school program on risk regulation research paper no 09-2; Yale Law School, Public law working paper no 190
Kaiser M (2012) Commentary: looking for conflict and finding none? Pub Underst Sci 21(2):188–194. doi:10.1177/0963662511434433
Keasling J (2009) Synthetic biology in pursuit of inexpensive, effective, anti-malarial drugs. BioSocieties 4(2–3):275–282. doi:10.1017/S1745855209990147
Kelle A (2009) Synthetic biology and biosecurity. EMBO Rep 10(S1):S23–S27
Kitney R, Freemont P (2012) Synthetic biology—the state of play. FEBS Lett 586(15):2029–2036
Kronberger N (2012) Synthetic biology: taking a look at a field in the making. Pub Underst Sci 21(2):130–133. doi:10.1177/0963662511426381
Kronberger N, Holtz P, Kerbe W, Strasser E, Wagner W (2009) communicating synthetic biology: from the lab via the media to the broader public. Syst Synth Biol 3(1–4):19–26. doi:10.1007/s11693-009-9031-x
Kronberger N, Holtz P, Wagner W (2012) Consequences of media information uptake and deliberation: focus groups’ symbolic coping with synthetic biology. Pub Underst Sci 21(2):174–187. doi:10.1177/0963662511400331
Krueger RA, Casey MA (2009) Focus groups: a practical guide for applied research, 4th edn. Sage Publications, Los Angeles
Kuckartz U (2012) Qualitative Inhaltsanalyse: Methoden, Praxis, Computerunterstützung. Beltz Juventa, Weinheim
Lehmkuhl M (2011) Die Repräsentation der synthetischen Biologie in der deutschen Presse. Abschlussbericht einer Inhaltsanalyse von 23 deutschen Pressetiteln. Deutscher Ethikrat, Berlin. http://www.ethikrat.org/dateien/pdf/lehmkuhl-studie-synthetische-biologie.pdf. Accessed 15 June 2015
Liamputtong P (2011) Focus group methodology: principle and practice. Sage, London
Lin AT (2011) Technology assessment 2.0: revamping our approach to emerging technologies. Brooklin Law Rev 76(4):1–62
Marris C, Rose N (2010) Open engagement: exploring public participation in the biosciences. PLoS Biol 8(11):e1000549
Mayring P (2008) Qualitative Inhaltsanalyse: Grundlagen und Techniken, 10th edn. Beltz, Weinheim
McHughen A (2007) Public perceptions of biotechnology. Biotechnol J 2(9):1105–1111. doi:10.1002/biot.200700071
Mohr A, Raman S (2012) Representing the public in public engagement: the case of the 2008 UK stem cell dialogue. PLoS Biol 10(11):e1001418
Nanz P, Fritsche M, Isaak A, Hofmann M, Lüdemann M (2010) Verfahren und Methoden der Bürgerbeteiligung. In: Bertelsmann Stiftung (ed) Politik beleben, Bürger beteiligen: Charakteristika neuer Beteiligungsmodelle. Gütersloh, pp 6–49
Nature Biotechnology (2009) What’s in a name? Nature Biotechnol 27(12):1071–1073
Navid EL, Einsiedel EF (2012) Synthetic biology in the science café: what have we learned about public engagement? J Sci Commun 11(4):1–9
Nuffield Council on Bioethics (2012) Emerging biotechnologies: technology, choice and the public good
OECD Royal Society (2010) Symposium on opportunities and challenges in the emerging field of synthetic biology. Synthesis report
Pardo R, Engelhard M, Hagen K, Jørgensen RB, Rehbinder E, Schnieke A, Szmulewicz M, Thiele F (2009) The role of means and goals in technology acceptance. A differentiated landscape of public perceptions of pharming. EMBO Rep 10(10):1069–1075. doi:10.1038/embor.2009.208
Pauwels E (2009) Review of quantitative and qualitative studies on U.S. public perceptions of synthetic biology. Syst Synth Biol 3(1–4):37–46. doi:10.1007/s11693-009-9035-6
Pauwels E (2013) Public understanding of synthetic biology. Bioscience 63(2):79–89. doi:10.1525/bio.2013.63.2.4
Pearson B, Snell S, Bye-Nagel K, Tonidandel S, Heyer L, Campbell AM (2011) Word selection affects perceptions of synthetic biology. J Biol Eng 5(1):9
Presidential Commission for the Study of Bioethical Issues (2010) New directions: the ethics of synthetic biology and emerging technologies. Washington, DC
Rehbinder E, Engelhard M, Hagen K, Jørgensen RB, Pardo-Avellaneda R, Schnieke A, Thiele F (2009) Pharming: promises and risks of biopharmaceuticals derived from genetically modified plants and animals, vol 35. Ethics of science and technology assessment. Springer, Berlin
Ro D-K, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, Chang MCY, Withers ST, Shiba Y, Sarpong R, Keasling JD (2006) Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440(7086):940–943. doi:http://www.nature.com/nature/journal/v440/n7086/suppinfo/nature04640_S1.html
Rowe G, Frewer LJ (2005) A Typology of public engagement mechanisms. Sci Technol Hum Values 30(2):251–290. doi:10.1177/0162243904271724
Royal Academy of Engineering (2009) Synthetic biology: public dialogue on synthetic biology. www.raeng.org.uk/synbiodialogue. Accessed 02 Apr 2015
Ruder WC, Lu T, Collins JJ (2011) Synthetic biology moving into the clinic. Science 333(6047):1248–1252. doi:10.1126/science.1206843
SCENIHR, SCCS, SCHER (2014) Opinion on synthetic biology I, Definition. http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_044.pdf. Accessed 17 Dec 2014
Schmidt M (ed) (2012) Synthetic biology: industrial and environmental applications. Wiley, Weinheim
Schmidt M, Torgersen H, Ganguli-Mitra A, Kelle A, Deplazes A, Biller-Andorno N (2008) SYNBIOSAFE e-conference: online community discussion on the societal aspects of synthetic biology. Syst Synth Biol 2(1–2):7–17. doi:10.1007/s11693-008-9019-y
Schön DA, Rein M (1994) Frame reflection: toward the resolution of intractrable policy controversies. Basic Books, New York
Seifert F (2002) Gentechnik - Öffentlichkeit - Demokratie: Der österreichische Gentechnik-Konflikt im internationalen Kontext. Profil-Verlag, München, Wien
Seifert F (2003) Demokratietheoretische Überlegungen zum österreichischen Gentechnik-Konflikt. SWS-Rundschau (1/2003):106–128
Service RF (2011) Algae’s second try. Science 333(6047):1238–1239. doi:10.1126/science.333.6047.1238
Sheedy A, MacKinnon MP, Pitre S, Watling J (2008) Handbook on citizen engagement: beyond consultation. Canadian Policy Research Networks Inc. Ottawa. http://cprn.org/documents/49583_EN.pdf. Accessed 23 Aug 2013
Stilgoe J, Lock SJ, Wilsdon J (2014) Why should we promote public engagement with science? Pub Underst Sci 23(1):4–15. doi:10.1177/0963662513518154
Stirling A (2008) “Opening up” and “closing down”: power, participation, and pluralism in the social appraisal of technology. Sci Technol Hum Values 33(2):262–294. doi:10.1177/0162243907311265
Stirling A (2012) Opening up the politics of knowledge and power in bioscience. PLoS Biol 10(1):e1001233
Tait J (2009) Upstream engagement and the governance of science. EMBO Rep 10(S1):S18–S22
Tait J (2012) Adaptive governance of synthetic biology. EMBO Rep 13(7):579
Thomas DD, Donnelly CA, Wood RJ, Alphey LS (2000) Insect population control using a dominant, repressible, lethal genetic system. Science 287(5462):2474–2476. doi:10.1126/science.287.5462.2474
Torgersen H (2009) Synthetic biology in society: learning from past experience? Syst Synth Biol 3(1–4):9–17. doi:10.1007/s11693-009-9030-y
Torgersen H, Hampel J (2012) Calling controversy: assessing synthetic biology’s conflict potential. Pub Underst Sci 21(2):134–148. doi:10.1177/0963662510389266
Torgersen H, Schmidt M (2013) Frames and comparators: how might a debate on synthetic biology evolve? Futures 48(100):44–54. doi:10.1016/j.futures.2013.02.002
United Nations Department of Economic and Social Affairs (2011) Guidelines on citizens’ engagement for development management and public governance. http://unpan1.un.org/intradoc/groups/public/documents/un-dpadm/unpan045265.pdf. Accessed 23 Aug 2013
van den Belt H (2009) Playing God in Frankenstein’s footsteps: synthetic biology and the meaning of life. Nanoethics 3(3):257–268. doi:10.1007/s11569-009-0079-6
Wang B, Wang J, Zhang W, Meldrum DR (2012) Application of synthetic biology in cyanobacteria and algae. Front Microbiol 3 doi:10.3389/fmicb.2012.00344
Weber W, Fussenegger M (2009) The impact of synthetic biology on drug discovery. Drug Discov Today 14(19–20):956–963. doi:10.1016/j.drudis.2009.06.010
Westfall PJ, Pitera DJ, Lenihan JR, Eng D, Woolard FX, Regentin R, Horning T, Tsuruta H, Melis DJ, Owens A, Fickes S, Diola D, Benjamin KR, Keasling JD, Leavell MD, McPhee DJ, Renninger NS, Newman JD, Paddon CJ (2012) Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci 109(3):E111–E118. doi:10.1073/pnas.1110740109
Wickson F, Delgado A, Kjolberg KL (2010) Who or what is ‘the public’? Nat Nano 5(11):757–758
Wynne B (2006) Public engagement as a means of restoring public trust in science—hitting the notes, but missing the music? Community Genet 9(3):211–220
Acknowledgements
The empirical data used in this study were generated in the framework of work conducted for the Austrian Research Promotion Agency (FFG) as partner of ERASynBio. Special thanks go to all participants in the CPs in Vienna and Innsbruck for their interest and willingness to discuss the issue of synthetic biology. I am especially grateful to my former supervisor Herbert Gottweis, who sadly passed away on March 31, 2014. His supervision and advice during data collection and analysis, and feedback on earlier drafts of this chapter were very valuable for me. I am indebted to Ursula Gottweis for her collaboration during script development, participant recruitment, and moderation of the CPs in Vienna and Innsbruck. Special thanks go to the organizers and participants at the International Summer School “Analyzing the Societal Dimensions of Synthetic Biology”, in Berlin, September 15–19, 2014, and to Ingrid Metzler, Katharina T. Paul, and Johannes Starkbaum from the University of Vienna for their inspiring and helpful feedback.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Steurer, W. (2016). “Some Kind of Genetic Engineering… Only One Step Further”—Public Perceptions of Synthetic Biology in Austria. In: Hagen, K., Engelhard, M., Toepfer, G. (eds) Ambivalences of Creating Life. Ethics of Science and Technology Assessment, vol 45. Springer, Cham. https://doi.org/10.1007/978-3-319-21088-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-21088-9_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-21087-2
Online ISBN: 978-3-319-21088-9
eBook Packages: EngineeringEngineering (R0)